Table 1 Baseline patient characteristics.

From: Evaluating the effect of 0.125% atropine on foveal microvasculature using optical coherence tomography angiography

 

n = 36 (63 eyes)

Age, year

8.9 ± 2.2

Gender (male: female)

21:15

Eye (right: left)

33:30

Follow-up period, months

8.8 ± 3.1

AL, mm

23.75 ± 0.88

cSE, D

−1.51 ± 1.02

Foveal thickness, µm

234.6 ± 16.4

FD-300, %

50.7 ± 4.1

FAZ area, mm2

0.28 ± 0.09

FAZ perimeter, mm

2.08 ± 0.35

AI

1.12 ± 0.04

  1. Continuous data are presented as mean ± SD.
  2. AL: axial length; cSE: cycloplegic spherical equivalent; FD-300: Foveal vessel density-300; FAZ: foveal avascular zone; AI: acircularity index.
Back to article page